Executive Management
Kurt A. Brykman
Kurt A. Brykman is President of PAREXEL Consulting and Medical Communications (PCMS). Mr. Brykman joined PAREXEL International in 2004 and oversaw the integration of its three consulting arms (WRA, PAREXEL / KMI, and Barnett Consulting) into one integrated consultancy. Mr. Brykman is an officer of PAREXEL and serves on the company's Executive Committee and Business Review Committee.
Prior to joining PAREXEL, Mr. Brykman worked at EURO RSCG Meridian Consulting Group, where he was Vice President and head of the Healthcare Practice. From 1988 to 2000, he held various senior marketing and sales positions with Schering-Plough, including that of Vice President of Customer Marketing in the Schering-Plough Healthcare Products division. At Schering-Plough, Mr. Brykman managed large organizations and significantly expanded the revenue and margin contribution of his areas of responsibility. Earlier in his career, he worked for GSK in brand management.
Mr. Brykman received his Bachelor of Science degree in Mathematics and General Business from Michigan State University. He received his MBA in Finance, Economics, and International Business from the Kellogg Graduate School of Management at Northwestern University.
Gadi Saarony
Gadi Saarony is Corporate Vice President and Worldwide Head, PAREXEL Consulting. Mr. Saarony joined PAREXEL International in 2003 as Director, Corporate Marketing Strategy and played a critical role in the transition of PAREXEL Consulting into one integrated consultancy from the former Worldwide Regulatory Affairs, Barnett Consulting, and PAREXEL / KMI. During this time Mr. Saarony fully transitioned to the role of Corporate Vice President, PAREXEL Consulting, to lead the firm’s GxP Strategic Compliance and Quality practice worldwide.
Before joining PAREXEL, Mr. Saarony was an Associate Director, Strategy, with Ernst & Young, LLP. He graduated from Rider University with a degree in Economics and a Masters degree in International Business (MBA) from The American Graduate School of International Business (Thunderbird).
Dr. Alberto Grignolo
Alberto Grignolo, Ph.D. is a Corporate Vice President at PAREXEL Consulting. A sixteen-year veteran of the firm who led and developed the Drug Development Consulting Practice to be recognized among the best in the world, he is now responsible for the firm’s Global Strategy and Services, including global registration strategies, worldwide clinical trial applications and marketing submissions, and scientific and technical expert advisory services for bio/pharmaceutical and medical device client companies, with a particular focus on Asia Pacific, Latin America and other emerging markets. He advises clients in the areas of drug development strategy, regulatory negotiation and best regulatory and clinical practices.
Dr. Grignolo is a Member of the Executive Committee of the Clinical Trials Transformation Initiative (CTTI), a Public Private Partnership between the FDA and Duke University aiming to increase the quality and efficiency of clinical trials. He was an Expert Adviser to the Institute of Medicine’s “Committee on Assessing the System for Protecting Human Research Participants” from 2000 to 2002. He was the winner of the 2008 Lifetime Achievement Award from the GCP Journal and was recognized as one of the 100 Most Inspiring People in the Life-Sciences Industry in 2008 by the readers of PharmaVOICE.
He is a past Chairman of the Board of the Regulatory Affairs Professionals Society (RAPS), has been involved in the advancement of the regulatory profession for most of his career, and was the recipient of the 1995 Richard E. Greco Professional of the Year Award from RAPS. He has been an active member of the Drug Information Association (DIA) since 1984, served on the DIA Board from 2000 until 2004, was the Chair of the Regulatory Track of the 2001, 2002 and 2003 DIA Annual Meetings, was the Chair of the 2007 DIA Annual Meeting and is an Instructor on the DIA Regulatory Training Faculty. He serves on the Graduate Faculty of the Massachusetts College of Pharmacy and Health Sciences in Boston as an Adjunct Associate Professor.
Prior to joining PAREXEL Consulting, Dr. Grignolo served as President of FIDIA Pharmaceutical Corporation and held regulatory positions at SmithKline & French Laboratories. After completing his undergraduate degree at Duke University, he earned a Doctorate in Experimental Psychology from the University of North Carolina and conducted postdoctoral research in neuropharmacology at Duke University Medical Center.
A native European who has also lived in Latin America and speaks four languages, Dr. Grignolo is a frequent speaker, instructor and participant at international conferences, seminars, workshops and courses on Drug Development and Regulatory Affairs.
Ron Kraus
Ron Kraus is Vice President Global Customer Strategy, PAREXEL Consulting, and manages the staff responsible for premier customer relationship management, and customer strategy planning in regard to how the firm can best assist with clients in optimizing their product development and management efforts.
Prior to his current role, Mr. Kraus was Vice President of the GxP Strategic Compliance and Operational Performance Excellence practice in North America in July 2007. He has over 12 years of domestic and international consulting experience including his role as Director, Consulting Services PAREXEL / KMI – European Operations from 2002 to 2004. Mr. Kraus joined PAREXEL / KMI in 1995 and held various positions of increasing responsibility.
Throughout his career with PAREXEL, Mr. Kraus has managed large (multi-national) compliance projects resulting in successful regulatory outcomes, functioned as a Quality Assurance “loaned executive” supporting the advancement of products through development, designed novel approaches for applying Risk Management concepts in a variety of commercial and development environments and has designed and implemented quality program improvements.
He is a faculty member of the PDA-TRI and a frequent speaker at industry conferences on topics including Process Validation, Supplier Selection, and Risk Management. Mr. Kraus received a B.S. degree in Mechanical Engineering (cum laude) from the University of Massachusetts and is a member of the Parenteral Drug Association.
